NEW YORK (GenomeWeb News) – Privately held eBioscience last week filed a suit against Invitrogen seeking a declaration that three patents exclusively licensed to the firm and two of its subsidiaries are invalid and that eBioscience is not infringing any claims in those patents.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Lawmakers have asked four direct-to-consumer genetic testing companies to explain their privacy policies and security measures, according to Stat News.

The Trump Administration has proposed a plan to reorganize the federal government, the Washington Post reports.

In Science this week: genetic overlap among many psychiatric disorders, and more.

The Economist writes that an increasing number of scientific journals don't do peer review.